Meet the labs of the Yale Cancer Biology Institute
-
Alarcón Lab
Uncovering the physiological and pathophysiological roles of RNA modifications at the molecular, cellular, and organism level through multidisciplinary approaches
-
Ferguson Lab
Defining therapeutic opportunities with growth factor receptors using structure
-
Kabeche Lab
Understanding the interplay between chromosomal instability and DNA damage response defects in cancers to uncover new cancer therapy targets
-
Klein Lab
Deciphering the structural underpinnings of oncogene activation to inform the rational design of antibody therapeutics
-
LaMarche Lab
We combine high-dimensional profiling of cancer patient tissues with detailed mechanistic studies in mouse models to develop new immunotherapies for solid tumors
-
Lemmon Lab
Understanding receptor tyrosine kinase signaling and how to correct aberrant activity when altered in diseases such as cancer
-
Liu Lab
Studying proteomics, protein turnover, and post-translational modifications to understand cancer aneuploidy, cellular signaling transduction, and biodiversity
-
Muzumdar Lab
Deciphering how genetic alterations interact with environmental and host factors to drive cancer development
-
Schlessinger Lab
Analyzing the mode of action of growth factor receptors and the intracellular signaling pathways that activated in response to growth factor stimulation
YCBI News
-
New Study Uncovers How Cancer Cells Tolerate Missing Chromosomes
A new study from the Cancer Biology Institute’s Yansheng Liu finds cancer cells tolerate missing chromosomes by boosting protein production
-
Cancer's progress detailed by 3D genomic maps
New findings from Mandar Deepak Muzumdar and Siyuan (Steven) Wang could improve cancer diagnostics and lead to new therapy targets
-
Protein turnover mapping may offer clues for Alzheimer’s, cancer treatment
The lab of Yansheng Liu has uncovered potential targets for treating Alzheimer’s disease and cancer